Navigation Links
Unilever Unveils Promise(R) SuperShots(R) for Blood Pressure, the First Functional Shot to Increase Daily Potassium Intake to Help Reduce the Risk of High Blood Pressure
Date:7/7/2008

e stay healthy longer."

For the past 40 years, Promise's mission has been to deliver delicious foods to promote a healthy lifestyle. Within the product portfolio, Promise(R) has heart healthy products which help people maintain heart health or lower their cholesterol. Healthy lifestyle information, education and recipes can be found at http://www.promisehealthyheart.com.

"Promise(R) SuperShots(R) are a significant addition to our Promise(R) brand of products, and the second in our growing line of vitality shot products in the United States," said Eric Berman, Brand Director, Promise(R). "We believe that we can empower consumers to take charge of their health and wellness by providing functional foods that can be a part of their diet and lifestyle. We're excited with this latest innovation as it represents our continuing commitment to delivering delicious foods that can help promote a healthy lifestyle."

Promise(R) SuperShots(R) are available at major retailers nationwide, priced at approximately $3.99 for a pack of four shots.

High blood pressure is a major public health concern affecting 73 million Americans -- nearly 1 in 3 adults -- and only 35% are able to control it. It is associated with an increased risk of death and illness from stroke, coronary heart disease, heart failure, and end-stage renal disease.(7)

About Promise(R)

Promise(R) spreads can help maintain a healthy heart when eaten instead of butter or margarine as part of a diet low in saturated fat, trans fat, and cholesterol.* Besides a wonderfully delicious buttery taste, cardiologists prefer the nutritional profile of Promise Buttery Spread to that of Smart Balance Buttery Spread.** Promise(R) spreads have a balanced blend of essential fatty acids and vitamins with 80% less saturated fat than butter, no cholesterol, no trans fats and are non-hydrogenated. Other products in the Promise(R) portfoli
'/>"/>

SOURCE Unilever
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Dr. Rani G Whitfield, M.D. Unveils The Legion of Health
2. AMA Launches Campaign to Cut Waste From Chaotic Insurance Claims Process, Unveils New Health Insurer Report Card
3. Function Drinks Unveils New Proprietary Packaging
4. Dubai Health Authority Unveils Healthcare for All
5. Photo: Bryan Adams Unveils Hear the World Ambassadors Photo Exhibit
6. Los Angeles Jewish Home Unveils Auerbach Behavioral Health Center Filling Community Void for Adults Over 55
7. Detour(R) Unveils Snack Size Protein Bar
8. Nations Vending Industry Unveils New Health Oriented Vending Program:
9. Qforma Unveils Managed Care Optimization Solution for Pharma Marketing Executives
10. CVS Caremark Charity Classic Golf Tournament Unveils 10th Anniversary Field
11. UHW Unveils Proposals for SEIU Convention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...gist explains prevalence of winter diaper rash and...sh season , COLLEGEVILLE, Pa., Dec. 2 /PRNewsw...per-clad babies, the winter months can mean cute l...nd not-so-cute and oh-so-painful little red bottom... until sunscreen season comes around again. , ...
(Date:12/2/2008)...alif., Dec. 2 The natio...oday to President-elect Obama urging him to fulfil...le and available by allowing any American to join ...a that a proposal pushed by health insurance compa...h insurance policies "amounts only to a government...
(Date:12/2/2008)...dy finds natural, less expensive treatments are ef... , PRINCETON, N.J., Dec. 2 Wi...oliday season is, for most, anticipated with excit... who suffer from Irritable Bowel Syndrome (IBS), t... embarrassing and debilitating gastrointestinal at...
(Date:12/2/2008)...nts treated with radiation prior to surgery for ad...r recurrence and better overall survival rates, ac...rt examined a treatment called neoadjuvant therapy...he spread of cancer, before surgery to remove the ...y and/or radiation. , Neoadjuvant therapy shoul...
Breaking Medicine News(10 mins):Health News:Photos: Heads Up, Parents: Get to the Bottom of Winter Diaper Rash 2Health News:Photos: Heads Up, Parents: Get to the Bottom of Winter Diaper Rash 3Health News:Photos: Heads Up, Parents: Get to the Bottom of Winter Diaper Rash 4Health News:Consumer Watchdog to Obama: Open Medicare to All Americans 2Health News:Consumer Watchdog to Obama: Open Medicare to All Americans 3Health News:Holiday Season Brings New Hope to Millions Who Suffer from Common Chronic Health Disorder 2
...00 personnel of the Central Reserve Police Force (...en found to be addicted to drugs and alcohol// , a...the survey to find out the number of men who have ...ound 426 alcohol and drug addicts," said a senior ...
...esearchers have discovered that fatty acid ethyl e...iably portray the extent of fetal alcohol exposure...e if an infant has been exposed to alcohol during ...trictly associated with alcohol use," said Enrique...
...e sector YES Bank has signed an MoU with a leading... up a 75-100 million dollar health care fund cater...hs. // The Netherlands-based equity house will ru...ank would be the advisor. This would be its first ...
...ing to a new study, men with prostate cancer are m...ional changes, which prevents them //from trustin...isconceptions on the disease management options an...f others with prostate cancer to their own conditi...
Other Medicine News:Health News:Misconception on Treatment Options among Prostate Cancer Patients 2
(Date:12/2/2008)...PRNewswire/ -- Horizon Therapeutics, Inc., a,priv...ced that two pivotal,Phase 3 trials evaluating it...,met all primary endpoints. HZT-501, a novel, pro...g ibuprofen and famotidine, demonstrated a,statis...non-steroidal,anti-inflammatory drug (NSAID)-indu...
(Date:12/1/2008)...AGO, Dec. 2 A study has... new technique for imaging the breast, is not affe...l status, two factors that limit the effectiveness...er. Results will be presented today at the annual ...ca (RSNA). , , "The ability of PEM to dete...
(Date:12/1/2008)...ewswire/ -- S*BIO Pte Ltd today announced the init...potent and orally-active JAK2 inhibitor, in leadin...hronic idiopathic myelofibrosis (CIMF). , , ... tolerability of SB1518 in patients with CIMF and ... 1 part of the study will assess the safety profil...
(Date:12/1/2008)...he Prox1 gene is a two-way switch that, if turned ...ogrammed so that they lose their identity and beco...MPHIS, Tenn., Dec. 1 S... have discovered that a certain differentiated cel...requires the constant expression of a gene called ...
Breaking Medicine Technology:Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Cell Therapeutics Inc 28CTI 29 Prices 241 27 million 28euros 856 000 29 Offering of Common Stock through Societe Generale 2589 1Cell Therapeutics Inc 28CTI 29 Prices 241 27 million 28euros 856 000 29 Offering of Common Stock through Societe Generale 2589 2BioSpecifics Technologies Corp Announces Sale of Stock in Private Placement Offering 2587 1Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer 9536 1Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer 9536 2Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer 9536 3Rwandas Gishwati Forest selected as site for historic conservation project 1899 1Rwandas Gishwati Forest selected as site for historic conservation project 1899 2Rwandas Gishwati Forest selected as site for historic conservation project 1899 3
...RE)--Apr 19, 2007 - Amgen,(NASDAQ: AMGN) today ann...d, double-blind, placebo-controlled, multicenter P...00 previously untreated,patients with extensive-st...um-containing chemotherapy. The study demonstrated...f death (overall,survival Aranesp compared to plac...
...Apr 18, 2007 - Critical,Therapeutics, Inc. (Nasdaq...rch demonstrating a role in chronic inflammatory,a...otein (HMGB1), a,pro-inflammatory mediator and nuc... May 2007 issue of Nature Immunology. The,publicat...es that,can stimulate immune cells to produce pote...
Other Medicine Technology:Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 2Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 3Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 4Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 5Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 6Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 7Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 2Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 3Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 4Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 5
...clear, all-silicone Foley catheters eliminate pati... designs. As an inert, toxin-free elastomer, silic... catheter. Unlike silicone-coated latex Foleys, Ro...leach chemicals or water-soluble proteins that can...
Used for stone manipulation and removal in the urinary tract. Enhanced wire strength permits the basket to expand the ureter more readily than standard flat-wire designs. The Unidex handle facilitate
Used for stone manipulation and removal in the urinary tract. Enhanced wire strength permits greater radial dilation in the ureter. The Unidex handle facilitates easy, ergonomic one-handed operation.
Used to establish and maintain nephrostomy drainage following pyeloplasty. The open ureteral segment promotes patency and allows the stent to adjust as edema subsides. Supplied sterile in peel-open p
Medicine Products: